Review of the efficacy of cytomegalovirus immune globulin in the prophylaxis of CMV disease in renal transplant recipients.
Snydman
D R
DR
Department of Medicine, New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111.
D000914:Antibodies, Viral / Q000008:administration & dosage*; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000628:therapy*; D006085:Graft Survival; D006801:Humans; D007116:Immunization, Passive; D016030:Kidney Transplantation; D011446:Prospective Studies; D012189:Retrospective Studies
D000914:Antibodies, Viral